Ostatní
Návod 
Integer Holdings Corporation
ITGR
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
2.4B
Obrat
2B
Zisk
0B
Aktiva
3B
Dluh
1B
ROE
0%
ROA
0%
PE
29
PS
2
Cena 1R
62-146
⌀ Cena
101.28
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
23-04-2026
Poslední dividenda
Profil
Společnost Integer Holdings Corporation působí jako externí výrobce zdravotnických prostředků ve Spojených státech, Portoriku, Kostarice a na mezinárodní úrovni. Působí v lékařských a nelékařských segmentech. Společnost nabízí produkty pro intervenční kardiologii, strukturální srdce, srdeční selhání, periferní cévní, neurovaskulární, intervenční onkologii, elektrofyziologii, cévní přístup, infuzní terapii, hemodialýzu, urologii a gastroenterologické procedury. Poskytuje také produkty pro řízení srdečního rytmu, včetně implantabilních kardiostimulátorů, implantabilních defibrilátorů kardiostimulátorů, vložitelných monitorů srdečního rytmu, implantabilních kardiostimulátorů a defibrilačních vedení a terapií srdečního selhání; neuromodulační produkty, jako jsou implantabilní stimulátory míchy; a nedobíjecí baterie, vstupní materiály, skříně přístrojů, obráběné komponenty a olovnaté komponenty a podsestavy. Společnost dále nabízí dobíjecí baterie a nabíječky a artroskopická, laparoskopická a obecná chirurgická zařízení a komponenty, jako jsou harmonické skalpely, holicí čepele, holicí strojky, vysokofrekvenční sondy, biopsie, trokary, elektrokauterní komponenty, obvazy ran, součásti léčby GERD a phacoemulzifikační jehly. Dále poskytuje ortopedické prostředky, které zahrnují nástroje používané při operacích kyčle, kolene a páteře, jakož i reamery a dláta. Společnost dále nabízí přizpůsobené systémy řízení spotřeby baterií a napájení a řešení baterií pro energetické, vojenské a ekologické trhy. Kromě toho společnost poskytuje lékařské technologie. Slouží nadnárodním výrobcům originálních zařízení a jejich přidruženým pobočkám na trzích kardiologie, neuromodulace, ortopedie, cév a pokročilé chirurgie a přenosné medicíny. Společnost Integer Holdings Corporation byla založena v roce 1970 a sídlí v Plano v Texasu.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
11000
Založení
2000-09-29
Podobné společnosti
$ 83.71
+ $ 1.92
$ 45.40
+ $ 0.53
$ 110.71
- $ 2.37
$ 28.16
+ $ 0.01
$ 70.80
+ $ 2.44
$ 231.91
+ $ 5.80
$ 31.23
- $ 0.69
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1,853.6 | 1,853.6 | 1,716.6 | 1,596.7 | 1,376.1 | 1,221.1 | 1,073.4 | 1,258.1 | 1,215.0 | 1,461.9 | 1,386.8 | 800.4 | 687.8 | 663.9 | 646.2 | 568.8 | 533.4 | |
| Cost of Revenues | 1,351.4 | 1,353.3 | 1,255.4 | 1,178.4 | 1,017.1 | 884.1 | 787.7 | 903.1 | 852.3 | 1,068.4 | 1,008.5 | 565.3 | 456.4 | 444.6 | 444.5 | 388.5 | 359.8 | |
| Gross Profit | 502.2 | 500.4 | 461.2 | 418.3 | 359.0 | 337.0 | 285.7 | 355.0 | 362.7 | 393.6 | 378.3 | 235.1 | 231.4 | 219.3 | 201.6 | 180.4 | 173.6 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 472.1 | 467.7 | 476.5 | 437.4 | 449.5 | 431.4 | 427.9 | 407.8 | 413.2 | 404.7 | |
| Cost of Revenues | 347.3 | 341.5 | 345.9 | 316.7 | 332.7 | 314.0 | 310.1 | 299.2 | 302.9 | 299.1 | |
| Gross Profit | 124.8 | 126.2 | 130.6 | 120.7 | 116.8 | 117.4 | 117.8 | 108.6 | 110.3 | 105.6 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 63.8 | 60.9 | 52.0 | 48.5 | 46.5 | 48.6 | 55.2 | 55.0 | 53.0 | 49.8 | 54.1 | 52.5 | 45.5 | 45.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 175.6 | 160.6 | 141.4 | 109.0 | 138.7 | 142.4 | 161.6 | 153.3 | 102.5 | 90.6 | 88.1 | 81.0 | 72.5 | 64.5 | |
| Depreciation & Amortization | 130.7 | 130.7 | 109.7 | 98.8 | 101.4 | 78.3 | 83.1 | 78.5 | 89.0 | 102.8 | 90.5 | 44.6 | 37.5 | 36.0 | 46.4 | 47.7 | 46.4 | |
| Total Operating Expenses | 277.2 | 260.8 | 252.9 | 251.0 | 221.5 | 201.3 | 165.1 | 197.4 | 207.1 | 254.1 | 270.0 | 222.0 | 155.7 | 158.0 | 175.8 | 118.7 | 114.1 | |
| Operating Income | 225.1 | 239.6 | 208.2 | 167.3 | 121.3 | 135.7 | 120.6 | 157.6 | 155.6 | 139.4 | 108.3 | 13.1 | 75.7 | 61.3 | 25.8 | 61.7 | 69.0 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.3 | 14.5 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 45.8 | 42.1 | ||
| Depreciation & Amortization | 35.5 | 33.0 | 32.3 | 29.8 | 27.6 | 28.7 | 27.2 | 26.2 | 25.1 | 19.1 | ||
| Total Operating Expenses | 65.0 | 69.7 | 71.3 | 71.2 | 59.8 | 59.4 | 63.3 | 69.9 | 66.7 | 56.7 | ||
| Operating Income | 59.7 | 56.4 | 59.3 | 49.6 | 57.0 | 58.0 | 54.5 | 38.7 | 43.5 | 48.1 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 43.2 | 43.2 | 56.4 | 53.4 | 38.6 | 31.6 | 38.2 | 52.5 | 99.3 | 106.5 | 111.3 | 33.5 | 4.3 | 11.3 | 18.1 | 16.9 | 18.5 | |
| Other Expense | -99.7 | -114.2 | -60.7 | -60.0 | -45.4 | -34.6 | -34.4 | -52.4 | 4.9 | -11.2 | 4.2 | 4.7 | 5.2 | -1.2 | -1.0 | 3.6 | 8.3 | |
| IBT | 125.4 | 125.4 | 147.6 | 107.3 | 76.0 | 101.1 | 86.2 | 105.2 | 61.1 | 21.8 | 1.2 | -15.7 | 76.6 | 48.8 | 6.7 | 48.4 | 49.3 | |
| Income Tax Expense | 22.6 | 22.6 | 26.5 | 16.6 | 10.6 | 8.0 | 8.9 | 14.0 | 14.1 | -44.9 | -4.8 | -8.1 | 21.1 | 12.6 | 11.5 | 15.3 | 16.2 | |
| Net Income | 102.8 | 102.8 | 119.9 | 90.7 | 66.4 | 96.8 | 77.3 | 96.3 | 168.0 | 66.7 | 6.0 | -7.6 | 55.5 | 36.3 | -4.8 | 33.1 | 33.1 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 12.0 | ||
| Interest Expense | 10.1 | 9.4 | 9.6 | 14.1 | 12.1 | 14.6 | 14.6 | 14.0 | 12.7 | 12.0 | ||
| Other Expense | -12.9 | -10.4 | -13.7 | -62.6 | -17.8 | -14.6 | -14.5 | -13.9 | -14.2 | -16.0 | ||
| IBT | 46.8 | 46.0 | 45.6 | -13.0 | 39.3 | 43.4 | 40.0 | 24.8 | 29.3 | 32.1 | ||
| Income Tax Expense | -1.8 | 6.3 | 8.6 | 9.5 | 6.3 | 7.1 | 8.8 | 4.2 | 3.0 | 4.8 | ||
| Net Income | 48.6 | 39.7 | 37.0 | -22.5 | 32.7 | 35.4 | 31.2 | 20.5 | 26.4 | 27.3 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $2.72 | $2.00 | $2.93 | $2.35 | $2.95 | $5.23 | $2.12 | $0.19 | $-0.29 | $2.23 | $1.51 | $-0.20 | $1.42 | $1.44 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $2.69 | $1.99 | $2.91 | $2.33 | $2.92 | $5.15 | $2.08 | $0.19 | $-0.29 | $2.14 | $1.43 | $-0.20 | $1.40 | $1.40 | |
| Shares Outstanding | 34.9 | 34.7 | 33.6 | 33.3 | 33.1 | 33.0 | 32.8 | 32.6 | 32.1 | 31.4 | 30.8 | 26.4 | 24.8 | 24.0 | 23.6 | 23.3 | 23.1 | |
| Diluted Shares Outstanding | 35.1 | 35.6 | 35.6 | 33.8 | 33.4 | 33.3 | 33.1 | 33.0 | 32.6 | 32.1 | 31.0 | 26.4 | 26.0 | 25.3 | 23.6 | 23.6 | 23.8 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.79 | $0.82 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.78 | $0.81 | ||
| Shares Outstanding | 34.9 | 35.1 | 35.0 | 33.9 | 33.7 | 33.7 | 33.6 | 33.5 | 33.4 | 33.3 | ||
| Diluted Shares Outstanding | 35.1 | 35.6 | 35.7 | 33.9 | 36.2 | 35.8 | 35.5 | 35.0 | 34.0 | 33.8 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 34.1 | 46.5 | 23.7 | 24.3 | 17.9 | 49.2 | 13.5 | 25.6 | 44.1 | 52.1 | 82.5 | 76.8 | 35.5 | 20.3 | 36.5 | 22.9 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 34.1 | 46.5 | 23.7 | 24.3 | 17.9 | 49.2 | 13.5 | 25.6 | 44.1 | 52.1 | 82.5 | 76.8 | 35.5 | 20.3 | 36.5 | 22.9 | |
| Accounts Receivable | 346.8 | 349.0 | 326.1 | 298.3 | 251.8 | 198.5 | 216.8 | 185.5 | 242.5 | 218.0 | 219.1 | 126.7 | 116.0 | 120.9 | 103.2 | 73.7 | |
| Inventory | 272.3 | 247.1 | 239.7 | 208.8 | 155.7 | 149.3 | 167.3 | 190.1 | 227.5 | 225.2 | 252.2 | 129.2 | 118.4 | 106.6 | 109.9 | 101.4 | |
| Other Current Assets | 23.7 | 28.4 | 28.1 | 27.0 | 27.6 | 15.9 | 17.9 | 15.1 | 17.8 | 22.0 | 20.9 | 17.9 | 12.7 | 20.3 | 15.3 | 13.5 | |
| Total Current Assets | 677.0 | 671.1 | 617.7 | 558.3 | 453.0 | 412.9 | 415.4 | 416.3 | 531.9 | 517.3 | 574.6 | 350.7 | 282.5 | 268.1 | 265.0 | 211.5 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 58.9 | 23.1 | 31.7 | 46.5 | 35.6 | 34.1 | 42.2 | 23.7 | 32.1 | 38.6 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 58.9 | 23.1 | 31.7 | 46.5 | 35.6 | 34.1 | 42.2 | 23.7 | 32.1 | 38.6 | |
| Accounts Receivable | 417.3 | 405.5 | 379.2 | 349.0 | 349.2 | 346.8 | 330.9 | 326.1 | 317.8 | 319.6 | |
| Inventory | 263.5 | 266.4 | 260.1 | 247.1 | 265.4 | 272.3 | 262.9 | 239.7 | 232.2 | 228.9 | |
| Other Current Assets | 38.4 | 42.4 | 31.2 | 28.4 | 79.8 | 23.7 | 32.7 | 28.1 | 27.2 | 28.8 | |
| Total Current Assets | 778.1 | 737.4 | 702.2 | 671.1 | 730.0 | 677.0 | 668.6 | 617.7 | 609.3 | 615.9 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 564.2 | 579.6 | 501.4 | 400.9 | 347.2 | 299.1 | 288.6 | 231.3 | 370.4 | 372.0 | 379.5 | 144.9 | 145.8 | 150.9 | 145.8 | 146.4 | |
| Goodwill | 1,042.2 | 1,017.7 | 1,011.0 | 982.2 | 924.7 | 859.4 | 839.6 | 832.3 | 990.2 | 967.3 | 1,013.6 | 354.4 | 346.7 | 349.0 | 338.7 | 307.5 | |
| Intangible Assets | 813.7 | 778.3 | 783.1 | 819.9 | 807.8 | 757.2 | 775.8 | 812.3 | 920.4 | 940.1 | 984.3 | 85.6 | 96.4 | 108.2 | 120.5 | 95.4 | |
| Long-Term Investments | 9.3 | 7.4 | 11.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 13.1 | 15.5 | 10.6 | 26.9 | 43.9 | 38.7 | 29.3 | 30.5 | 31.3 | 31.8 | 26.6 | 17.8 | 16.4 | 11.1 | 8.9 | 13.8 | |
| Total Long-Term Assets | 2,449.4 | 2,406.9 | 2,325.0 | 2,236.1 | 2,129.2 | 1,958.9 | 1,937.7 | 1,910.4 | 2,316.4 | 2,315.2 | 2,407.5 | 605.3 | 608.2 | 621.7 | 616.4 | 565.5 | |
| Total Assets | 3,126.4 | 3,078.0 | 2,942.7 | 2,794.4 | 2,582.2 | 2,371.9 | 2,353.1 | 2,326.7 | 2,848.3 | 2,832.5 | 2,982.1 | 956.0 | 890.7 | 889.9 | 881.3 | 777.0 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 648.7 | 644.4 | 625.0 | 579.6 | 568.1 | 564.2 | 544.6 | 489.6 | 440.1 | 427.7 | |
| Goodwill | 1,098.8 | 1,100.4 | 1,082.4 | 1,017.7 | 1,033.1 | 1,042.2 | 1,043.9 | 1,011.0 | 979.9 | 986.0 | |
| Intangible Assets | 837.7 | 854.5 | 856.2 | 778.3 | 805.2 | 813.7 | 828.9 | 783.1 | 779.1 | 797.6 | |
| Long-Term Investments | 7.6 | 7.5 | 7.6 | 7.4 | 10.2 | 9.3 | 9.3 | 11.8 | 10.4 | 13.9 | |
| Other Long-Term Assets | 25.5 | 18.1 | 23.5 | 23.0 | 14.2 | 13.1 | 13.8 | 22.4 | 14.1 | 13.8 | |
| Total Long-Term Assets | 2,619.2 | 2,633.5 | 2,595.5 | 2,406.9 | 2,437.6 | 2,449.4 | 2,447.4 | 2,325.0 | 2,230.0 | 2,245.4 | |
| Total Assets | 3,397.3 | 3,370.9 | 3,297.7 | 3,078.0 | 3,167.6 | 3,126.4 | 3,116.0 | 2,942.7 | 2,839.3 | 2,861.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 119.4 | 101.5 | 120.3 | 110.8 | 76.9 | 51.6 | 65.0 | 57.2 | 83.5 | 77.9 | 84.4 | 46.4 | 46.5 | 45.3 | 40.7 | 28.0 | |
| Short-Term Debt | 8.7 | 25.7 | 10.6 | 28.6 | 25.1 | 45.9 | 45.0 | 37.5 | 30.5 | 31.3 | 29.0 | 11.3 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 72.8 | 92.6 | 80.1 | 78.8 | 53.9 | 56.2 | 67.1 | 67.4 | 21.2 | 17.7 | 17.5 | 8.4 | 45.3 | 46.5 | 53.4 | 32.6 | |
| Current Liabilities | 206.0 | 227.2 | 221.0 | 223.8 | 159.6 | 156.2 | 179.1 | 164.6 | 209.0 | 185.2 | 213.8 | 108.7 | 91.8 | 91.8 | 94.0 | 60.6 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 110.7 | 117.4 | 112.0 | 101.5 | 116.8 | 119.4 | 116.2 | 120.3 | 108.4 | 107.5 | |
| Short-Term Debt | 9.1 | 8.9 | 8.7 | 25.7 | 13.9 | 8.7 | 8.6 | 10.6 | 20.0 | 25.2 | |
| Other Current Liabilities | 85.5 | 87.0 | 82.1 | 92.6 | 86.1 | 72.3 | 64.8 | 80.1 | 72.5 | 64.1 | |
| Current Liabilities | 209.8 | 216.0 | 206.4 | 227.2 | 222.4 | 206.0 | 201.4 | 221.0 | 203.1 | 199.8 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1,118.5 | 1,081.6 | 1,042.7 | 979.1 | 872.6 | 731.6 | 814.4 | 888.0 | 1,578.7 | 1,698.8 | 1,685.1 | 176.3 | 197.5 | 225.4 | 236.0 | 220.6 | |
| Capital Leases | 85.4 | 113.4 | 93.3 | 82.4 | 69.6 | 46.3 | 44.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 144.1 | 124.6 | 145.6 | 160.7 | 171.5 | 182.3 | 188.0 | 203.9 | 145.4 | 208.6 | 221.8 | 53.2 | 52.0 | 82.5 | 75.2 | 64.3 | |
| Total Liabilities | 1,572.5 | 1,458.8 | 1,423.6 | 1,376.9 | 1,227.5 | 1,100.8 | 1,200.6 | 1,266.2 | 1,955.0 | 2,107.3 | 2,131.5 | 342.6 | 348.6 | 409.0 | 414.1 | 350.1 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1,302.0 | 1,312.2 | 1,345.9 | 1,081.6 | 1,157.5 | 1,204.0 | 1,225.9 | 1,042.7 | 1,006.2 | 1,048.1 | |
| Capital Leases | 117.3 | 118.6 | 119.4 | 108.8 | 92.0 | 85.4 | 85.2 | 72.3 | 74.8 | 77.7 | |
| Def. Tax Liability | 114.7 | 114.7 | 111.2 | 124.6 | 143.2 | 144.1 | 145.2 | 145.6 | 151.4 | 152.9 | |
| Total Liabilities | 1,651.5 | 1,667.4 | 1,691.0 | 1,458.8 | 1,546.5 | 1,572.5 | 1,591.0 | 1,413.2 | 1,376.0 | 1,415.7 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | 823.1 | 891.2 | 771.4 | 680.7 | 614.3 | 517.5 | 440.3 | 344.5 | 176.1 | 109.1 | 231.9 | 239.4 | 184.0 | 147.7 | 152.5 | 119.4 | |
| Comprehensive Income | 0.6 | -14.0 | 20.2 | 5.3 | 27.2 | 52.7 | 20.0 | 33.0 | 52.2 | -16.0 | 1.4 | 9.1 | 14.4 | 12.9 | 8.9 | 10.5 | |
| Total Common Equity | 1,553.9 | 1,619.2 | 1,519.0 | 1,417.5 | 1,354.7 | 1,271.1 | 1,152.5 | 1,060.5 | 893.4 | 725.2 | 850.6 | 613.4 | 542.1 | 480.9 | 467.3 | 426.8 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | 945.4 | 905.8 | 868.8 | 891.2 | 858.5 | 823.1 | 791.9 | 771.4 | 745.0 | 717.7 | |
| Comprehensive Income | 61.6 | 63.9 | 10.7 | -14.0 | 26.5 | 0.6 | 7.9 | 20.2 | -3.0 | 12.2 | |
| Total Common Equity | 1,745.8 | 1,703.5 | 1,606.7 | 1,619.2 | 1,621.2 | 1,553.9 | 1,525.0 | 1,519.0 | 1,463.3 | 1,445.7 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 1,212.7 | 1,103.5 | 1,053.2 | 1,007.7 | 897.8 | 777.6 | 859.4 | 925.5 | 1,609.2 | 1,730.2 | 1,714.1 | 187.5 | 197.5 | 225.4 | 236.0 | 220.6 | |
| Book Value | 1,553.9 | 1,619.2 | 1,519.0 | 1,417.5 | 1,354.7 | 1,271.1 | 1,152.5 | 1,060.5 | 893.4 | 725.2 | 850.6 | 613.4 | 542.1 | 480.9 | 467.3 | 426.8 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 1,745.8 | 1,703.5 | 1,606.7 | 1,619.2 | 1,621.2 | 1,553.9 | 1,525.0 | 1,519.0 | 1,463.3 | 1,445.7 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 105.4 | 102.8 | 119.9 | 90.7 | 66.4 | 96.8 | 77.3 | 96.3 | 168.0 | 66.7 | 6.0 | -7.6 | 55.5 | 36.3 | -4.8 | 33.1 | 33.1 | |
| Depreciation & Amortization | 103.0 | 130.7 | 111.0 | 98.8 | 92.0 | 81.4 | 79.3 | 77.9 | 89.0 | 102.8 | 90.5 | 44.6 | 37.5 | 36.0 | 46.4 | 47.7 | 46.4 | |
| Stock-Based Compensation | 24.3 | 23.2 | 24.8 | 23.3 | 21.0 | 16.2 | 9.2 | 9.3 | 10.5 | 14.7 | 8.4 | 9.4 | 13.2 | 14.1 | 10.9 | 12.1 | 6.9 | |
| Change Working Capital | -62.6 | -120.4 | -54.6 | -52.3 | -75.8 | -47.7 | 16.2 | -40.1 | -9.9 | 3.4 | -6.0 | -59.3 | -18.5 | -7.0 | -16.8 | -6.8 | 8.6 | |
| Change In Accounts Receivable | -4.7 | -89.7 | -25.0 | -21.1 | -41.4 | -17.5 | 38.2 | -7.0 | 9.3 | -34.6 | -2.2 | 3.7 | -11.7 | 7.4 | -18.8 | -13.5 | 10.9 | |
| Change In Accounts Payable | 5.8 | -0.6 | -16.6 | -0.5 | 26.0 | 19.5 | -9.1 | 1.9 | -0.1 | 4.9 | -1.1 | 3.1 | -1.0 | 1.3 | 5.8 | 4.2 | -7.6 | |
| Change In Inventories | -35.8 | -2.6 | -18.1 | -30.2 | -56.7 | 4.7 | 18.4 | 3.7 | -16.1 | -1.0 | 22.2 | -25.8 | -6.7 | -11.5 | -7.5 | -2.1 | 7.4 | |
| Other Non-cash Items | 175.0 | 62.6 | 18.2 | 29.2 | 30.3 | 20.3 | 6.4 | 32.2 | -151.3 | 21.0 | 14.0 | 35.7 | -6.8 | 7.3 | 23.5 | -4.9 | -33.6 | |
| Cash from Operations | 187.8 | 0.0 | 0.0 | 180.2 | 116.4 | 156.7 | 181.3 | 165.4 | 167.3 | 149.4 | 105.5 | 12.5 | 81.3 | 56.8 | 64.8 | 89.9 | 76.9 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 48.6 | 39.7 | 37.0 | -22.5 | 32.7 | 35.4 | 31.2 | 20.5 | 26.4 | 27.3 | |
| Depreciation & Amortization | 35.5 | 33.0 | 32.3 | 29.8 | 28.9 | 28.7 | 27.2 | 26.2 | 25.1 | 24.5 | |
| Stock-Based Compensation | 0.0 | 4.9 | 5.7 | 6.9 | 6.0 | 6.1 | 5.8 | 6.8 | 6.2 | 5.5 | |
| Change Working Capital | -30.9 | -13.6 | -35.5 | -40.4 | 59.4 | -4.3 | -20.9 | -34.3 | -5.0 | -2.6 | |
| Change In Accounts Receivable | -40.8 | -9.7 | -22.2 | -17.0 | 11.5 | -9.8 | -10.6 | 2.4 | -6.2 | 9.7 | |
| Change In Accounts Payable | -3.8 | -8.4 | 1.4 | 10.2 | -20.9 | -2.8 | 4.4 | 2.7 | 0.3 | -1.7 | |
| Change In Inventories | 9.7 | 2.3 | -6.8 | -7.7 | 13.4 | -4.3 | -10.0 | -17.3 | -4.4 | -4.1 | |
| Other Non-cash Items | 8.9 | 1.5 | 4.6 | 53.4 | -49.7 | 5.5 | 3.9 | 4.0 | 11.8 | 7.6 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 55.0 | 62.3 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -122.8 | 0.0 | 0.0 | -119.9 | -74.7 | -53.5 | -51.4 | -48.2 | -44.9 | -47.3 | -58.6 | -44.6 | -24.8 | -18.6 | -41.1 | -22.5 | -16.1 | |
| Acquisitions | -182.0 | -178.9 | -138.5 | -43.6 | -126.6 | -218.0 | -5.2 | -15.0 | 581.4 | 0.0 | 0.0 | -423.4 | -13.3 | 4.7 | -17.2 | -66.5 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | -1.2 | -1.3 | -3.0 | -6.3 | 2.2 | -3.7 | -1.9 | 10.3 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.3 | -2.2 | 0.3 | 0.4 | 10.3 | 0.0 | |
| Other Investing Activities | -168.1 | 0.0 | 0.0 | 0.2 | 0.6 | 0.4 | 0.1 | 4.8 | 1.4 | 0.7 | -1.7 | -5.6 | 2.2 | -1.1 | 0.0 | -12.0 | 2.2 | |
| Cash from Investing | -304.8 | 0.0 | 0.0 | -163.4 | -200.4 | -271.0 | -56.6 | -58.9 | 536.7 | -47.9 | -63.3 | -473.6 | -35.9 | -18.3 | -59.8 | -80.4 | -13.9 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -27.5 | 0.0 | 0.0 | 0.0 | -19.1 | -26.0 | -31.2 | -29.1 | -37.1 | -25.5 | |
| Acquisitions | -8.0 | 170.9 | 1.1 | -172.0 | 0.0 | 0.0 | 0.6 | -139.1 | -43.5 | 0.1 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -80.6 | -25.4 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -256.0 | 0.0 | 0.0 | 27.6 | -71.1 | -805.0 | -272.5 | -150.5 | -705.5 | -178.6 | -46.0 | -1,232.2 | -10.0 | -458.3 | -32.0 | -40.0 | -78.5 | |
| Debt Issued | 405.5 | 1,103.5 | 50.3 | 73.2 | 181.0 | 925.2 | 190.7 | 84.4 | 21.8 | 57.6 | 62.1 | 2,758.7 | 0.0 | 430.4 | 21.5 | 55.3 | 299.1 | |
| Issuance of Common Stock | -1.2 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.8 | 6.6 | 8.3 | 12.8 | 1.3 | 2.4 | 0.7 | |
| Repurchase of Common Stock | -10.8 | -50.0 | 0.0 | -3.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 24.8 | 0.0 | 0.0 | -42.5 | 163.4 | 886.9 | 183.9 | 32.6 | -19.6 | 66.9 | -29.0 | 1,693.5 | -0.7 | 422.1 | 9.3 | 41.3 | -1.0 | |
| Cash from Financing | 113.2 | 0.0 | 0.0 | -18.0 | 92.5 | 82.0 | -88.6 | -117.9 | -725.1 | -111.7 | -72.1 | 467.9 | -2.4 | -23.4 | -21.5 | 3.7 | -78.8 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 17.6 | -43.3 | |
| Debt Issued | 1,311.2 | -10.0 | -33.5 | 251.1 | -67.8 | -41.4 | -21.8 | 193.5 | 42.3 | -3.6 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.3 | 0.4 | |
| Repurchase of Common Stock | -50.0 | 0.0 | -2.6 | -14.1 | -0.2 | -0.1 | 0.0 | 0.0 | 0.0 | -0.1 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 17.5 | -43.1 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -4.5 | -29.4 | 22.9 | -0.6 | 6.4 | -31.3 | 35.7 | -12.0 | -18.5 | -8.0 | -30.4 | 5.7 | 41.4 | 15.2 | -16.2 | 13.6 | -15.0 | |
| Closing Cash Balance | 34.1 | 17.2 | 46.5 | 23.7 | 24.3 | 17.9 | 49.2 | 13.5 | 25.6 | 44.1 | 52.1 | 82.5 | 76.8 | 35.5 | 20.3 | 36.5 | 22.9 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -41.8 | 35.8 | -8.6 | -14.8 | 11.0 | 1.4 | -8.0 | 18.5 | -8.5 | -6.5 | |
| Closing Cash Balance | 17.2 | 58.9 | 23.1 | 31.7 | 46.5 | 35.6 | 34.1 | 42.2 | 23.7 | 32.1 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 65.0 | 105.1 | 99.6 | 60.3 | 41.7 | 103.2 | 129.9 | 117.2 | 122.4 | 102.1 | 46.9 | -32.1 | 56.5 | 38.2 | 23.8 | 67.4 | 60.7 | |
| Real Free Cash Flow | 40.7 | 81.9 | 74.8 | 37.0 | 20.6 | 87.0 | 120.7 | 107.9 | 111.9 | 87.4 | 38.5 | -41.5 | 43.3 | 24.1 | 12.9 | 55.4 | 53.9 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 27.9 | 46.3 | 69.1 | 6.1 | 44.1 | 45.2 | 16.1 | -5.8 | 17.9 | 36.8 | |
| Real Free Cash Flow | 27.9 | 41.3 | 63.4 | -0.8 | 38.1 | 39.1 | 10.3 | -12.7 | 11.8 | 31.3 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 28.7 | 36 | 179.3 |
| P/S | 1.6 | 1.9 | 390.6 |
| P/B | 1.7 | 2.1 | 113.4 |
| P/FCF | 22.4 | 30.8 | 149.9 |
| Market cap | $2.4 | $3.1 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 35.6 % | 0 % |
| Debt to Income | 1275.3 % | 1196.8 % | 0 % |
| Debt to Free cash flow | 994.3 % | 9.7 % | 0 % |
| Interest expense percentage | 19.2 % | 52.2 % | 11.2 % |
| Current ratio | 3.7 | 2.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 5.9 % | 5.8 % | 0 % |
| ROA | 3 % | 3 % | 0 % |
| CapEx to Revenue | 1.5 % | 4.3 % | 6 % |
| RaD to Revenue | 0 % | 5.4 % | 0 % |
| ROEM | 168,512.5 | 49282.6 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 27.1 % | 29 % | 61.9 % |
| Operating margin | 12.1 % | 9.8 % | 17.9 % |
| Net margin | 5.5 % | 5.4 % | 13 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 35.1 mil | 30.1 mil |
| Employee count | 11.0 tis | 5.0 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
